The Enterprise Value as of December 2025 (TTM) for CanSino Biologics Inc. (CASBF) is 12.42B

According to CanSino Biologics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.42B. This represents a change of -28.12% compared to the average of 17.28B of the last 4 quarters.

CanSino Biologics Inc. (CASBF) Historical Enterprise Value (quarterly & annually)

How has CASBF Enterprise Value performed in the past?

The mean historical Enterprise Value of CanSino Biologics Inc. over the last ten years is 62.07B. The current 12.42B Enterprise Value has changed 1.90% with respect to the historical average. Over the past ten years (40 quarters), CASBF's Enterprise Value was at its highest in in the June 2021 quarter at 188.87B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

CanSino Biologics Inc. (CASBF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CanSino Biologics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CanSino Biologics Inc. (CASBF) Average Enterprise Value

How has CASBF Enterprise Value performed in the past?

The current Enterprise Value of CanSino Biologics Inc. (CASBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CanSino Biologics Inc. (CASBF) Enterprise Value vs. Peers

How is CASBF’s Enterprise Value compared to its peers?

CanSino Biologics Inc.’s Enterprise Value is less than Tsumura & Co. (296.02B), less than Hisamitsu Pharmaceutical Co., Inc. (200.62B), greater than Sihuan Pharmaceutical Holdings Group Ltd. (8.92B), greater than Curaleaf Holdings, Inc. (2.96B), greater than Dermapharm Holding SE (2.91B), greater than Almirall, S.A. (2.87B), greater than Fagron N.V. (1.85B), less than China Medical System Holdings Limited (26.85B), less than Aspen Pharmacare Holdings Limited (71.44B), less than Nippon Shinyaku Co., Ltd. (282.70B),

Build a custom stock screener for CanSino Biologics Inc. (CASBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanSino Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CanSino Biologics Inc. (CASBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CanSino Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.